Market News Today — AI-Curated Stock & Crypto Headlines

Powered by 6 AI Providers

Gemini Groq DeepSeek FinBERT OpenAI Free Analysis
🤖 6 AI Models ⚡ Real-time 📊 Sentiment Analysis
All Stocks Crypto Economy AI Commodities Tech Regulation Global Trusted Sources
Showing news for SLNO Back to SLNO
Clear filter

🧭 Daily Market Digest (Apr. 8, 2026) 🤖 AI-Powered

FinBERT analysis of financial text showing neutral sentiment with 42.4% confidence.

Trending Market Signals

High-confidence AI analysis of developments with immediate market relevance

No High-Impact Signals

Markets are stable — no major high-confidence signals detected at this time.

Check back soon or explore latest news below for developing stories.

Latest News (2 articles)

Stocks MarketWatch
1d ago
Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.

Soleno Therapeutics stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy …

Neurocrine's potential acquisition of Soleno Therapeutics is driving a surge in Soleno's stock price, with … High (80%)
View full analysis →
$SLNO $NBIX $NVS $PFE $ABBV
MarketWatch Neutral
Global Markets & Finance Financial Times
2d ago
Neurocrine nears $2.5bn-plus deal for biotech behind obesity disorder treatment

Soleno Therapeutics makes first commercialised drug for extreme hunger caused by Prader-Willi syndrome

Neurocrine is nearing a $2.5bn-plus deal to acquire Soleno Therapeutics, the biotech company behind the … High (80%)
View full analysis →
$NBIX $SLNO
Financial Times Neutral

No articles match your filters.

Get Market Intelligence Daily

AI-curated news and analysis — free, straight to your inbox.

🤖

Market Insight

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
Analyzing...
AI Model Multi-Provider AI
Open article